A Phase I Study of IDP-73152 Mesylate in Health Male Volunteer

NCT01904318 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

56

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: IDP-73152 mesylate 40 mg
DRUG: IDP-73152 mesylate 80 mg
DRUG: IDP-73152 mesylate 160 mg
DRUG: IDP-73152 mesylate 320 mg
DRUG: IDP-73152 mesylate 640 mg
DRUG: IDP-73152 mesylate 1280 mg
DRUG: Placebo

Sponsor

IlDong Pharmaceutical Co Ltd